Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Guidant Boosts CHF Resynchronization Therapy R&D With VivoMetrics Deal

This article was originally published in The Gray Sheet

  • News

Executive Summary

Guidant looks to use VivoMetrics' LifeShirt ambulatory monitoring system in an upcoming congestive heart failure registry after reaching a purchasing agreement with the firm Dec. 4

You may also be interested in...



Guidant Launches Next Phase Of Heart Failure Registry To Promote ICDs

Guidant is turning from randomized trials to national patient registries to identify underserved heart failure patient groups that can benefit from implantable cardioverter defibrillators

Guidant Launches Next Phase Of Heart Failure Registry To Promote ICDs

Guidant is turning from randomized trials to national patient registries to identify underserved heart failure patient groups that can benefit from implantable cardioverter defibrillators

Guidant COMPANION Results Support Contak CD Mortality Benefit

Guidant's Contak CD cardiac resynchronization therapy pacemaker/ICD demonstrated a 40% reduction in all-cause mortality compared with optimum medical therapy, data from the firm-sponsored COMPANION study show

Table

View full table

Tags:
Latest Headlines

GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health

FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility

‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports

Lilly Can Rest Easy As Tirzepatide Scores Phase III Sleep Apnea Win

See All
UsernamePublicRestriction

Register

MT017593

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By